Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Oda%2C+Takeaki%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Oda%2C+Takeaki%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Oda%2C+Takeaki%22&type=Person&sort=year
PubPharm (23)
1
NEUROTRIMIN FUNCTION INHIBITOR
enthalten in:
Europäisches Patentamt
| 2024
von
AKIYAMA TETSU
|
KAMOSHIDA YUKI
|
HAYASHI TOMOATSU
| +3
Wird geladen...
2
NEUROTRIMIN FUNCTION INHIBITOR
enthalten in:
Europäisches Patentamt
| 2024
von
AKIYAMA TETSU
|
KAMOSHIDA YUKI
|
HAYASHI TOMOATSU
| +3
Wird geladen...
3
LncRNA ZNNT1 induces p53 degradation by interfering with the interaction between p53 and the SART3-USP15 complex
enthalten in:
PNAS nexus
| 2023
von
Taniue, K.
|
Oda, T.
|
Hayashi, T.
| +11
Wird geladen...
4
PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER, COLORECTAL CANCER, BILIARY TRACT CANCER AND LIVER CANCER, PROPHYLACTIC OR THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
enthalten in:
Europäisches Patentamt
| 2023
von
AKIYAMA TETSU
|
HAYASHI TOMOATSU
|
YAMAZUMI YUSUKE
| +1
Wird geladen...
5
PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER, COLORECTAL CANCER, BILIARY TRACT CANCER AND LIVER CANCER, PROPHYLACTIC OR THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
enthalten in:
Europäisches Patentamt
| 2023
von
AKIYAMA TETSU
|
HAYASHI TOMOATSU
|
YAMAZUMI YUSUKE
| +1
Wird geladen...
6
Prophylactic or therapeutic agent for at least one cancer selected from group consisting of pancreatic cancer, lung cancer, colorectal cancer, bile duct cancer, and liver cancer, prophylactic or therapeutic agent for cancer used in compound medicine combined with said agent, combined medicine comprising said agent, and method for screening for prophylactic or therapeutic agent for cancer
enthalten in:
Europäisches Patentamt
| 2022
von
AKIYAMA TORU
|
LIN KUANDUN
|
YAMAZUMI YUSUKE
| +1
Wird geladen...
7
Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5
enthalten in:
Europäisches Patentamt
| 2022
von
AKIYAMA TETSU
|
HARADA HIROAKI
|
YAMAZUMI YUSUKE
| +3
Wird geladen...
8
PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER, COLORECTAL CANCER, BILIARY TRACT CANCER AND LIVER CANCER, PROPHYLACTIC OR THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
enthalten in:
Europäisches Patentamt
| 2021
von
AKIYAMA TETSU
|
HAYASHI TOMOATSU
|
YAMAZUMI YUSUKE
| +1
Wird geladen...
9
PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER, COLORECTAL CANCER, BILIARY TRACT CANCER AND LIVER CANCER, PROPHYLACTIC OR THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
enthalten in:
Europäisches Patentamt
| 2021
von
AKIYAMA TETSU
|
HAYASHI TOMOATSU
|
YAMAZUMI YUSUKE
| +1
Wird geladen...
10
METHOD FOR SCREENING PROPHYLACTIC OR THERAPEUTIC AGENTS FOR DISEASES CAUSED BY INTERLEUKIN 6, INTERLEUKIN 13, TNF, G-CSF, CXCL1, CXCL2, OR CXCL5 AND AGENT FOR THE PREVENTION OR TREATMENT OF DISEASES CAUSED BY INTERLEUKIN 6, INTERLEUKIN 13, TNF, G-CSF, CXCL1, CXCL2, OR CXCL5
enthalten in:
Europäisches Patentamt
| 2020
von
AKIYAMA TETSU
|
HARADA HIROAKI
|
YAMAZUMI YUSUKE
| +3
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
23
Aufsätze
20
E-Artikel
20
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
13
Europäisches Patentamt
3
EMBO reports
2
Biochemical and biophysical research communicat...
1
Cell reports
1
Development (Cambridge, England)
1
Experimental and therapeutic medicine
1
Oncogene
1
PNAS nexus
Alle anzeigen ...
weniger ...
Thema
13
615
13
A61P: Specific therapeutic activity of chemical...
13
G01N: Investigating or analysing materials by d...
13
bio
13
che
13
tec
12
C12N: Microorganisms or enzymes; compositions t...
11
A61K: Preparations for medical, dental, or toil...
11
C12Q: Measuring or testing processes involving ...
9
Journal Article
7
Research Support, Non-U.S. Gov't
5
C07K: Peptides (peptides containing β-lactam r...
3
A01K: Animal husbandry; aviculture; apiculture;...
3
RNA-Binding Proteins
3
hor
2
A23L: Foods, foodstuffs, or non-alcoholic bever...
2
MEX3B protein, mouse
2
MicroRNAs
2
Transcription Factors
2
Tumor Suppressor Protein p53
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
12
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
22
Englisch
Haven't found what you're looking for?
Wird geladen...